On the current debate on lowering LDL cholesterol with ezetimibe Reply

被引:0
|
作者
Erdmann, Erland [1 ]
机构
[1] Univ Klin Koln, Innere Med Klin 3, Herzzentrum Univ Koln, D-50937 Cologne, Germany
关键词
D O I
10.1055/s-0030-1267501
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2202 / 2202
页数:1
相关论文
共 50 条
  • [31] NEW DRUGS FOR LOWERING LDL-CHOLESTEROL
    Badescu, Codruta
    Rezus, Elena
    Badescu, L.
    Dima, Nicoleta
    Rezus, C.
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2016, 120 (03): : 485 - 490
  • [32] Oxidation of LDL cholesterol - Reply
    Okada, M
    Hoshiyama, M
    ANNALS OF CLINICAL BIOCHEMISTRY, 1998, 35 : 158 - 158
  • [33] LDL-cholesterol lowering and renal outcomes
    Waters, David D.
    CURRENT OPINION IN LIPIDOLOGY, 2015, 26 (03) : 195 - 199
  • [34] LDL-cholesterol lowering: to be or not to be too low
    Duprez, Daniel
    Jacobs Jr, David R.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2023, 30 (12) : 1205 - 1206
  • [35] No limit to the benefits of LDL-cholesterol lowering
    Gregory B. Lim
    Nature Reviews Cardiology, 2015, 12 (8) : 444 - 444
  • [36] The effects of ezetimibe on LDL-cholesterol: Quantitative or qualitative changes?
    Rizzo, Manfredi
    Rini, Giovam Battista
    Spinas, Giatgen A.
    Berneis, Kaspar
    ATHEROSCLEROSIS, 2009, 204 (02) : 330 - 333
  • [37] Variability of the LDL-C lowering response to ezetimibe and ezetimibe plus statin therapy in hypercholesterolemic patients
    Descamps, Olivier
    Tomassini, Joanne E.
    Lin, Jianxin
    Polis, Adam B.
    Shah, Arvind
    Brudi, Philippe
    Hanson, Mary E.
    Tershakovec, Andrew M.
    ATHEROSCLEROSIS, 2015, 240 (02) : 482 - 489
  • [38] Sequence variation in NPC1L1 and association with improved LDL-cholesterol lowering in response to ezetimibe treatment
    Simon, JS
    Karnoub, MC
    Devlin, DJ
    Arreaza, MG
    Qiu, P
    Monks, SA
    Severino, ME
    Deutsch, P
    Palmisano, J
    Sachs, AB
    Bayne, ML
    Plump, AS
    Schadt, EE
    GENOMICS, 2005, 86 (06) : 648 - 656
  • [39] Utility of Pre-Treatment Non-Cholesterol Sterols in the Prediction of LDL-C Lowering Response to Statins and Ezetimibe
    Williams, Paul T.
    Dansinger, Michael L.
    Superko, H. R.
    Schaefer, Ernst J.
    CIRCULATION, 2019, 140
  • [40] Cholesterol guidelines debate - Reply
    Newman, TB
    Garber, AM
    PEDIATRICS, 2001, 107 (05) : 1230 - 1230